Evidence map›Paper›PMID 20176021›Full record

ReviewGastroenterology2010

Genetic approaches to functional gastrointestinal disorders.

Yuri A Saito, Nandita Mitra, Emeran A Mayer

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Ion channelopathies in functional GI disorders.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Review
  16. Towards a systems view of IBS.Nature reviews. Gastroenterology & hepatology · 2015
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Yuri A SaitoC.E.N.T.E.R., Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Nandita Mitra
Emeran A Mayer
Mayo Clinic · USUniversity of California, Los Angeles · USUniversity of Pennsylvania · US

Funding

Women's Health and Functional Visceral Disorders CenterP50DK064539 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2002 to 2017
$17.5M
PERCEPTION AND MODULATION OF VISCERAL SENSATIONSR01DK048351 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 1996 to 2019
$8.2M
Mind/Brain/Body Interactions in Stress-Related DisordersR24AT002681 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2004 to 2008
$4.6M
A candidate gene association study of irritable bowel syndromeR03DK076797 · NIDDK · MAYO CLINIC ROCHESTER · PI SAITO LOFTUS, YURI ANN · 2008 to 2009
$151k
NCCIH NIH HHS AT002681NCCIH NIH HHS R24 AT002681NIDDK NIH HHS DK48351NIDDK NIH HHS DK64539NIDDK NIH HHS DK76797NIDDK NIH HHS P50 DK064539NIDDK NIH HHS R01 DK048351NIDDK NIH HHS R03 DK076797
6 · The paper itself

Abstract

Functional gastrointestinal disorders are complex symptom-based disorders without agreed upon biomarkers or pathophysiology. A better understanding of the genetic architecture of these disorders would help to better identify their complex biology and explain the common comorbidity with other disorders of persistent pain, mood, and affect, as well as possibly make it possible to identify subgroups of patients who respond to customized therapies. In contrast to monogenic diseases, polygenic diseases and traits are characterized by the contribution of common variants in a large number of genes, as well as environmental factors, to the vulnerability of an individual. Family and twin studies have clearly established a genetic component in irritable bowel syndrome. Although candidate gene studies have identified a few gene polymorphisms that may be correlated with the syndrome, small sample size, lack of reproducibility in large data sets, and the unreliability of the clinical phenotype require caution when extrapolating to a major role of any of the reported polymorphisms in the pathophysiology of irritable bowel syndrome. Future progress in this area will require better characterization of intermediate phenotypes with large effect size for the clinical phenotype, as well as consideration of gene-gene, environment-gene (epigenetics), and sex-gene interactions, genome-wide association, and whole genome sequencing approaches in large data sets.

Indexed as

Epistasis, GeneticFalse Positive ReactionsGenome-Wide Association StudyHumansIrritable Bowel SyndromePhenotypePolymorphism, GeneticSequence Analysis, DNATwin Studies as Topic

Identifiers

PMID20176021
PMCPMC3829382
OpenAlexW2001416500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.